Joint EDQM EPAA JRC EURL ECVAM Workshop on Quality Control of Veterinary Vaccines
Since the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes opened for signature in 1986, the European Pharmacopoeia Commission and its experts have made significant progress in Replacing, Reducing and Refining (3Rs) the use of animals in tests for the development and control of medicinal products.
The EDQM, in collaboration with the EPAA and JRC EURL ECVAM, is organising a workshop entitled ‘Novel in vitro model as alternative to in vivo toxoid vaccines testing: Clostridium septicum vaccine as a proof of concept’, on 25 and 26 January 2021 in Strasbourg, France.
Who should attend?
About EPAA and EURL ECVAM
EPAA is a Public-Private Partnership across seven industry sectors and between European Commission and Industry stakeholders. Launched in 2005, it gathers 37 companies, 8 European trade federations and 5 Directorates-General of the European Commission.
Further information is available here.
EURL ECVAM is an integral part of the Joint Research Centre (JRC, Ispra, Italy), the science and knowledge service of the European Commission. Its mandate, as specified in Directive 2010/63/EU, is linked to the advancement of the Replacement, Reduction and Refinement (the Three Rs) of animal procedures. Current activities cover research and collaboration with research initiatives, validation studies, dissemination of information, knowledge sharing, promotion of alternative methods in an international context across disciplines and sectors. Further information is available here.